Background: Heterozygous Familial hypercholesterolemia (FH) is a common autosomal dominant disorder resulting in in very high blood cholesterol levels and premature cardiovascular disease (CVD). However, there is a wide variation in the occurrence of CVD in these patients. The aim of this study is to determine risk factors that are responsible for the variability of CVD events in FH patients. Methods: This is a retrospective analysis of a large multiethnic cohort of patients with definite FH attending the Healthy Heart Prevention Clinic in Vancouver, Canada. Cox proportional hazard regression analysis was used to assess the association of the risk factors to ...
International audienceBACKGROUND: Heterozygous familial hypercholesterolemia (heFH) is a ă genetic d...
The goal of this study was to determine cardiovascular disease (CVD) risk associated with familial h...
International audienceBackground and aims: Heterozygous familial hypercholesterolemia (HeFH) is incr...
Background: Heterozygous Familial hypercholesterolemia (FH) is a common autosomal d...
Background: Familial hypercholesterolemia (FH) is a common autosomal dominant disorder caused by mu...
BACKGROUND: Heterozygous familial hypercholesterolemia (hFH) and familial combined hyperlipidemia (F...
Familial hypercholesterolemia (FH) is a common genetic cause of elevated low-density lipoprotein cho...
International audienceObjective: Familial hypercholesterolemia (FH) is associated with a high risk o...
Background: The role of lipoprotein(a) [Lp(a)] as a predictor of cardiovascular disease (CVD) in pat...
International audienceBACKGROUND: Heterozygous familial hypercholesterolemia (heFH) is a genetic dis...
Background and aims: Familial hypercholesterolaemia (FH) is a known major cause of premature heart d...
textabstractFamilial hypercholesterolemia (FH) (OMIM #143890) is an autosomal dominant disorder pres...
AbstractPurposeThe goal of this study was to determine cardiovascular disease (CVD) risk associated ...
OBJECTIVES: To assess the clinical and biochemical factors associated with inter-individual variatio...
Background and aims: Familial combined hyperlipidemia (FCHL) is a complex dyslipidemia associated wi...
International audienceBACKGROUND: Heterozygous familial hypercholesterolemia (heFH) is a ă genetic d...
The goal of this study was to determine cardiovascular disease (CVD) risk associated with familial h...
International audienceBackground and aims: Heterozygous familial hypercholesterolemia (HeFH) is incr...
Background: Heterozygous Familial hypercholesterolemia (FH) is a common autosomal d...
Background: Familial hypercholesterolemia (FH) is a common autosomal dominant disorder caused by mu...
BACKGROUND: Heterozygous familial hypercholesterolemia (hFH) and familial combined hyperlipidemia (F...
Familial hypercholesterolemia (FH) is a common genetic cause of elevated low-density lipoprotein cho...
International audienceObjective: Familial hypercholesterolemia (FH) is associated with a high risk o...
Background: The role of lipoprotein(a) [Lp(a)] as a predictor of cardiovascular disease (CVD) in pat...
International audienceBACKGROUND: Heterozygous familial hypercholesterolemia (heFH) is a genetic dis...
Background and aims: Familial hypercholesterolaemia (FH) is a known major cause of premature heart d...
textabstractFamilial hypercholesterolemia (FH) (OMIM #143890) is an autosomal dominant disorder pres...
AbstractPurposeThe goal of this study was to determine cardiovascular disease (CVD) risk associated ...
OBJECTIVES: To assess the clinical and biochemical factors associated with inter-individual variatio...
Background and aims: Familial combined hyperlipidemia (FCHL) is a complex dyslipidemia associated wi...
International audienceBACKGROUND: Heterozygous familial hypercholesterolemia (heFH) is a ă genetic d...
The goal of this study was to determine cardiovascular disease (CVD) risk associated with familial h...
International audienceBackground and aims: Heterozygous familial hypercholesterolemia (HeFH) is incr...